Common variable immunodeficiency (CVID) is characterized by hypogammaglobulinemia and defects in T-cell functions that could be primary or secondary. We addressed whether CVID is associated with impairment in the dendritic cell (DC) compartment, as DC play a central role in the development of adaptive immunity. We demonstrate that DC from CVID patients display severely perturbed differentiation, maturation and function, and expressed markedly reduced levels of the co-stimulatory molecules that are critical for T-cell stimulation. Patients' DC induced weak proliferation of allogeneic T-cells and produced significantly low amounts of IL-12 upon CD40 signalling. Multiple defects in the immune system, including malfunctioning of DC, appear to be prominent features of CVID patients. Impairment in both the innate and adaptive compartments of the immune system may thus cumulatively account for the inability of CVID patients to eradicate pathogens through conventional immune pathways thus resulting in an increased risk for recurrent bacterial infections.
Introduction
Common variable immunodeficiency (CVID) is a heterogeneous group of disorders characterized by hypogammaglobulinemia, and a number of T-and B-cell defects. 1-9 The fact that some patients' B-cells can secrete IgM and IgG in vitro, while patients being hypogammaglobulinemic in vivo, implies that B-cells may not receive appropriate signalling for class switch and affinity maturation10-12 and that perturbed cellular interactions in germinal centres may be involved in the pathogenesis of the disease. Under physiological conditions, immune responses are initiated in the T-cell areas of secondary lymphoid organs, where naive T-cells encounter dendritic cells (DC).13 DC-derived cytokines play a crucial role in the cascade of events leading to priming of naive T-cells. The T-helper cells in turn induce B-cell growth and antibody production. However, direct interactions between DC and B-cells also occur. 13 As DC play a critical role in bridging innate and adaptive immunity, we addressed the issue of whether CVID is associated with an impaired DC compartment.
Study design

Patients and dendritic cells
Heparinized blood samples were collected from ten CVID patients at least 21 days following the last infusion of intravenous immunoglobulin (IVIg) (patients 1 to 10), and from two newly diagnosed naïve CVID patients prior to IVIg therapy (patients 11 and 12), upon approval by local ethical committees. CVID patients were heterogeneous in clinical presentation and were associated with recurrent pneumonia, granulomatous disease, lamblia or autoimmune diseases (Supplementary Table 1 ). As control, blood samples were obtained from three patients (patients 1, 2 and 3) with selective antibody deficiencies (deficiency in IgG4; IgG2 and IgG4; and IgG4 and IgA respectively) and one patient with hyper IgM syndrome (patient 4) who received IVIg similar to CVID patients and from six healthy controls. Monocyte-derived DC from patients' blood and from control groups were generated as described 14 in the presence of 10% autologous plasma.
For allogeneic mixed lymphocyte reaction (MLR), DC from CVID patients and healthy donors were exposed to CD4+ T-cells of third party healthy donors. 14 The CD4+ T-cells were isolated by MACS cell isolation kit (Miltenyi Biotech, Bergisch Gladbach, Germany). Figure 1A and 1B) . The expression of HLA-DR (mean fluorescence intensity, MFI: 131.6 ± 58.4), CD11c (224.4 ± 150.7) and CD40 (160.6 ± 72.4) ( Figure 1C ) on CVID patients' DC was also significantly lower than that of DC from healthy donors (n=6) (201.5 ± 108.5; 397.7 ± 189.8 and 269.5 ± 112.9 for HLA-DR, CD11c and CD40 respectively) and control patients (n=4) (312.5 ± 182.7; 262.5 ± 27.4 and 323.8 ± 240.6 for HLA-DR, CD11c and CD40 respectively) (P<0.05; Mann-Whitney test) indicative of an impaired differentiation of DC in patients with CVID. The defective differentiation of DC from CVID patients was also observed in the presence of AB serum or serum-free medium, thus excluding the possible influence of patients' plasma components on differentiation. The defects in DC were not due to IVIg replacement therapy since defects were also observed in newly diagnosed naïve CVID patients, and in patient having received IVIg six months prior to obtaining blood sample (patient T-cell numbers in their peripheral blood. 9 Therefore, it is the impaired function of T-cells that may be responsible for the pathogenesis in these patients. In addition, we report on the diminished production of IL-12 by DC and reduced expression of CD40, CD80 and other co-stimulatory molecules involved in DC-T-cell cross-talk. We thus suggest that impairment in both the innate and adaptive compartments of the immune system cumulatively account for the inability of CVID patients to eradicate pathogens through conventional immune pathways. 23 Thus, defective DC function along with impaired T-cell activity will have serious repercussion on the humoral immune response of CVID patients. Multiple defects in the immune system, including defective DC function, thus appear to be prominent features of CVID.
Results and Discussion
For 
